Umair Anjum
@umairanjum1997
Followers
99
Following
45
Media
3
Statuses
42
Research Scholar @MayoClinic | Alumnus @Dow_Uni
Scottsdale, AZ
Joined May 2024
We try to explore the advances being made in the field of PSMA guided theranostics and what the future might bring in this niche. I am very thankful to my co-authors and mentors who guided me through this manuscript, @Parminder1699 @EphraimParent
https://t.co/GiYxxDavO3
mdpi.com
Following lung cancer, prostate cancer is the leading cause of cancer death in men. High-risk localized tumor burden or metastatic disease often progresses, refractory to initial treatment regimens....
1
5
19
A weekend full of memories with the BEACON Lab in Sedona 🌄 Our last trip together before wrapping up, and a first for the new faces joining us. Thank you @IrbazRiaz for making it happen — hikes, BBQ, and moments I’ll never forget. #BEACONLab #Sedona
0
3
25
So happy and proud to share our recent publication on the much talked about topic of Bladder Preservation in NMIBC/MIBC, under the expert mentorship of Dr. Singh. Truly grateful for Dr. Singh’s guidance 🙏🏻😊😇. @Parminder1699 @MarkTysonMD @durant_adri
https://t.co/PvYR33sDZ2
link.springer.com
Current Oncology Reports - In recent years, new, effective bladder sparing techniques have emerged as favorable options for patients with BCG-unresponsive high-grade non-muscle-invasive bladder...
3
6
8
From rotating here as a medical student to matching here for internal medicine residency, dreams do come true. Extremely grateful for the phenomenal mentorship by @IrbazRiaz. It was an incredible experience contributing to research in AI at @MayoClinic! Next Stop @CCF_IMCHIEFS
35
13
543
Heterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-analysis https://t.co/LP4jDNUMTV This living meta-analysis (LMA) evaluates the differential efficacy of PARP
1
19
29
Now, Dr. @Parminder1699 masterfully outlines the role of chemo-immunotherapy in urothelial carcinoma at @OncLive AZ highlighting the current state of evidence in an insightful and informative session w/ @IrbazRiaz @AlanBryce9 @ZakhariaYousef
0
5
10
Dr. @AlanBryce9 & @IrbazRiaz delivering an insightful talk at @OncLive, expertly breaking down the evolving treatment landscape of advanced #ProstateCancer with clarity and precision. If only we could all articulate it that eloquently! w/ @Parminder1699.
0
7
15
Congratulations Dr @IrbazRiaz!!
🎉 Honored to be named a Gerstner Scholar in AI Translation at @MayoClinic! Excited to advance AI-driven innovations in oncology—leveraging large language models (LLMs) to enhance clinical trial outreach and patient communication, ensuring better access and engagement. Grateful
0
1
8
Excited to co-chair this first GU summit with @bilenma in Atlanta with great lineup of speakers @PBarataMD @CParkMD @RohanGarjeMD @maughanonc @binayshah @arnabguonc @virajmaster @DocMattCampbell @BasselNazha and many more can’t find on X, 15 travel grants offered to trainees.
📅 Join us at the Atlanta Genitourinary Cancers Summit on Mar. 15, co-chaired by Winship medical oncologist Mehmet Asim Bilen, MD, and Mayo Clinic's Yousef Zakharia, MD. Experts will discuss advancements in prostate, kidney, bladder cancers and more. ➡️ https://t.co/rpe4LAULYQ
3
19
61
🚀 Proud moment for our BEACON | Riaz Lab team at #ASCOGU25! Our talented team are driving innovation in AI and health outcomes with impactful presentations. 🎤📊 Big thanks to our mentors for their support! @ZakhariaYousef @Parminder1699
#Oncology #AI #GU25 @MayoClinic
5
14
52
Very excited and honored to present our work on “Survival in advanced prostate cancer (PCa) patients with visceral metastases: A population based SEER study” at #ASCOGU25 Really grateful to @IrbazRiaz for this opportunity and his invaluable mentorship. #GU25 #RiazLab
3
7
56
It was a pleasure meeting you and presenting our poster, @jrgralow. I appreciate you taking the time to stop by and look forward to staying in touch! #ASCOGU25 @ASCO
Fun catching up with GU friends and colleagues at #GU25 @ASCO @DrChoueiri @JessicaHawleyMD @crisbergerot @NazliDizman @TiansterZhang @KainatWarraich6 @drulkav
1
3
16
Honored to present my poster, “Heterogeneity in Subgroup Reporting Across Clinical Trials Assessing Systemic Therapies in Metastatic Castration-Resistant Prostate Cancer: A Living Systematic Review,” at #ASCOGU25 ! Grateful for the opportunity @IrbazRiaz
#RiazLab #mCRPC
0
4
20
Honored to present our work on “Sociodemographic Predictors of Late-stage Diagnosis in Patients with Prostate Cancer: A Retrospective Cohort Study” at #ASCOGU25 Special thanks to @IrbazRiaz for this opportunity. It has been a remarkable experience. #prostatecancer #RiazLab
1
3
14
#GU25 @IrbazRiaz @SyedArsalanN @muhammadalik_ @SalmanAJajja @umairanjum1997 @Malik_UmairAyub @neerajaiims @ZakhariaYousef @MayoCancerCare @MayoClinic excellent performance at ASCO GU by Mayo clinic research fellows with 12 posters in prostate kidney and bladder cancer
1
8
42
1/4: Excited to share that our work on "Collaborative large language models for automated data extraction in living systematic reviews" has been published in the @JAMIA_Journal. Grateful to @IrbazRiaz @cbaral @M_Hassan_Murad @JeannePalmerMD for their support and guidance.
2
7
20
Excited to be a part of this living systematic review and meta-analysis! Thank you for the opportunity @IrbazRiaz @SyedArsalanN
1/4 - Delighted to share our living SRMA on PARPi in mCRPC presenting data from 13 trials w/ 4278 pts; Grateful to @AlanBryce9, @IrbazRiaz @ParminderSingh @JakeOrmeMDPhD for their phenomenal mentorship and guidance. Published in @EUplatinum ( https://t.co/HLUDkzbxbk)
0
2
4
Excited to share our editorial in @AnnalsofIM where we discuss the evolving role of GCs in precision oncology & the need for robust evidence to guide clinical decisions w/ @IrbazRiaz 🔗 Read here:
acpjournals.org
Prostate cancer gene classifier tests could influence treatment decisions despite lack of evidence for long-term outcomes. Researchers note a need for better data on their cost-effectiveness, clinical utility, and their impact on racial and ethnic groups, particularly Black men.
0
2
7
4/4 - I'd like to thank all collaborators & coauthors for this effort @Silke_Gillessen @neerajaiims @SylvanBacaLab @ProfSyedHussain @quimmateo @sartor_oliver #JeremyWarner #DanChilds #DrMurad @ewan_cobran @umairanjum1997 @muhammadalik_ @arifabibi5 #AmmadRaina @ManalImran260
0
2
6
3/4 - What makes this publication unique? It’s a living, interactive review! 🖥️ Our findings are presented on a web-based platform that will be periodically updated with new clinical trial(s) data—keeping evidence current and interactive ( https://t.co/nN5SyEYBt7)
1
2
4